Screening and public health strategies for diabetic retinopathy in the Eastern Mediterranean Region

Middle East African Journal of Ophthalmology

Volumn 19, Issue 2, 2012, Pages 178-184

  Khandekar, Rajiv ^a  

^a MINISTRY OF HEALTH   (Oman)

Author keywords

Diabetes; Diabetic Retinopathy; Public Health Policy; Retina; Screening; VISION 2020

Indexed keywords

CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC RETINOPATHY; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; INCIDENCE; LIFESTYLE MODIFICATION; MASS SCREENING; MEDICAL INFORMATION SYSTEM; OPHTHALMOSCOPY; PATIENT COUNSELING; PATIENT SAFETY; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REHABILITATION CARE; REVIEW; SOUTHERN EUROPE; STRATEGIC PLANNING; VALIDATION PROCESS;

DIABETIC RETINOPATHY; GUIDELINES AS TOPIC; HUMANS; INCIDENCE; MASS SCREENING; MEDITERRANEAN REGION; PREVALENCE; PUBLIC HEALTH;

EID: 84860428531     PISSN: 09749233     EISSN: 09751599     Source Type: Journal    
DOI: 10.4103/0974-9233.95245     Document Type: Review

References (57)

1. Hennekens CH, Burring JE, Myrent SL. Screening in Epidemiology in Medicine. Boston, USA: Little Brown and Company; 1987. p. 327-50.
2. Miller AB, Goel V. Screening. In: Detels R, McEwen J, Bealehole R, Tanaka H, editors. Oxford Textbook of Public Health. 4th ed., vol. 3. UK: Oxford University Press; 2002. p. 1822-35.
3. Yanoff M, Duker JS. Diabetic retinopathy. In: Ophthalmology. St. Louis: Mosby; 2004. p. 877-86.
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
5. Boscia F. Current approaches to the management of diabetic retinopathy and diabetic macular oedema. Drugs. 2010;70:2171-200.
6. Gündüz K, Bakri SJ. Management of proliferative diabetic retinopathy. Compr Ophthalmol Update 2007;8:245-56.
7. O'Doherty M, Dooley I, Hickey-Dwyer M. Interventions for diabetic macular oedema: A systematic review of the literature. Br J Ophthalmol 2008;92:1581-90.
8. World Health Organization. Diabetic Retinoopathy; Disease Control and Prevention of Visual impairment in 'VISION 2020 Global Initiative for the Elimination of Avoidable Blindness: Action Plan 2006-2011'. Geneva, Switzerland; 2007. p. 34-6.
9. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: A global public health problem and a new definition. J Atheroscler Thromb 2005;12:295-300.
10. Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al.; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004;122:552-63. (Pubitemid 38456292)
11. Klein R, Lee KE, Knudtson MD, Gangnon RE, Klein BE. Changes in visual impairment prevalence by period of diagnosis of diabetes: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 2009;116:1937-42.
12. World Health organization. Country Profile. Available from: http://www.emro.who.int/emrinfo/index.aspx?Ctry=afg. [Last Accessed on 2010 Jan 17].
13. Diabetes in the Eastern Mediterranean Region. Available from: http://www.emro.who.int/ncd/pdf/Diabetes-in-EMRO.pdf. [Last Accessed on 2010 Jan 17].
14. Country presentation: Bahrain in 'World Health Organization. Regional workshop on the planning for the control and prevention of blindness due to diabetic retinopathy'; 2008. p. 28-9. WHO-EM/CPB/005/E/07.08/250.
15. Al-Adsani AM. Risk factors for diabetic retinopathy in Kuwaiti type 2 diabetic patients. Saudi Med J 2007;28:579-83.
16. Khandekar R, Al Lawatii J, Mohammed AJ, Al Raisi A. Diabetic retinopathy in Oman: A hospital based study. Br J Ophthalmol 2003;87:1061-4. (Pubitemid 37064875)
17. Elshafei M, Gamra H, Khandekar R, Al Hashimi M, Pai A, Ahmed MF. Prevalence and determinants of diabetic retinopathy among persons = 40 years of age with diabetes in Qatar: A community-based survey. Eur J Ophthalmol 2011;21:39-47.
18. Khan AR, Wiseberg JA, Lateef ZA, Khan SA. Prevalence and determinants of diabetic retinopathy in Al hasa region of Saudi Arabia: Primary health care centre based crosssectional survey, 2007-2009. Middle East Afr J Ophthalmol 2010;17:257-63.
19. Saadi H, Carruthers SG, Nagelkerke N, Al-Maskari F, Afandi B, Reed R, et al. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract 2007;78:369-77. (Pubitemid 350030313)
20. Bamashmus MA, Gunaid AA, Khandekar RB. Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: A hospital-based study. Indian J Ophthalmol 2009;57:293-8.
21. Macky TA, Khater N, Al-Zamil MA, El Fishawy H, Soliman MM. Epidemiology of diabetic retinopathy in Egypt: A hospital-based study. Ophthalmic Res 2010;45:73-8.
22. Al-Till MI, Al-Bdour MD, Ajlouni KM. Prevalence of blindness and visual impairment among Jordanian diabetics. Eur J Ophthalmol 2005;15:62-8. (Pubitemid 40462731)
23. Javadi MA, Katibeh M, Rafati N, Dehghan MH, Zayeri F, Yaseri M, et al. Prevalence of diabetic retinopathy in Tehran province: A population-based study. BMC Ophthalmol 2009;9:12.
24. Mahar PS, Awan MZ, Manzar N, Memon MS. Prevalence of type-II diabetes mellitus and diabetic retinopathy: The Gaddap study. J Coll Physicians Surg Pak 2010;20:528-32.
25. Salti HI, Nasrallah MP, Taleb NM, Merheb M, Haddad S, El- Annan J, et al. Prevalence and determinants of retinopathy in a cohort of Lebanese type II diabetic patients. Can J Ophthalmol 2009;44:308-13.
26. Elmahdi EM, Kaballo AM, Mukhtar EA. Features of non-insulindependent diabetes mellitus (NIDDM) in the Sudan. Diabetes Res Clin Pract 1991;11:59-63.
27. Ben Abdelaziz A, Drissi L, Tlili H, Gaha K, Soltane I, Amrani R, et al. [Epidemiologic and clinical features of patients with type 2 diabetes mellitus in primary care facilities (Sousse, Tunisie)]. Tunis Med 2006;84:415-22. (Pubitemid 44519525)
28. Kadiki OA, Roaed RB. Epidemiological and clinical patterns of diabetes mellitus in Benghazi, Libyan Arab Jamahiriya. East Mediterr Health J 1999;5:6-13.
29. Perumalsamy N, Prasad NM, Sathya S, Ramasamy K. Software for reading and grading diabetic retinopathy: Aravind Diabetic Retinopathy Screening 3.0. Diabetes Care 2007;30:2302-6. (Pubitemid 47359037)
30. Benbassat J, Polak BC. Reliability of screening methods for diabetic retinopathy. Diabet Med 2009;26:783-90.
31. Stolar M. Glycemic control and complications in type 2 diabetes mellitus. Am J Med 2010;123 Suppl 3:S3-11.
32. Barrios V, Escobar C. Diabetes and hypertension. What is new? Minerva Cardioangiol 2009;57:705-22.
33. Chatziralli IP, Sergentanis TN, Keryttopoulos P, Vatkalis N, Agorastos A, Papazisis L. Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. BMC Res Notes 2010;3:153.
34. Ruamviboonsuk P, Teerasuwanajak K, Tiensuwan M, Yuttitham K; Thai Screening for Diabetic Retinopathy Study Group. Interobserver agreement in the interpretation of single-field digital fundus images for diabetic retinopathy screening. Ophthalmology 2006;113:826-32.
35. Classé JG. Pupillary dilation: An eye-opening problem. J Am Optom Assoc 1992;63:733-41.
36. Sinclair SH. Diabetic retinopathy: The unmet needs for screening and a review of potential solutions. Expert Rev Med Devices 2006;3:301-13.
37. Tran TH, Rahmoun J, Hui Bon Hoa AA, Denimal F, Delecourt F, Jean Jean E, et al. [Screening for diabetic retinopathy using a three-field digital nonmydriatic fundus camera in the North of France]. J Fr Ophtalmol 2009;32:735-41.
38. Liew G, Mitchell P, Wang JJ, Wong TY. Fundoscopy: To dilate or not to dilate? BMJ 2006;332:3. (Pubitemid 43061726)
39. Chopra V, Varma R, Francis BA, Wu J, Torres M, Azen SP; Los Angeles Latino Eye Study Group. Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles Latino Eye Study. Ophthalmology 2008;115:227-32.
40. Kwan AS, Barry C, McAllister IL, Constable I. Fluorescein angiography and adverse drug reactions revisited: The Lions Eye experience. Clin Experiment Ophthalmol 2006;34:33-8. (Pubitemid 43379368)
41. Yang CS, Sung CS, Lee FL, Hsu WM. Management of anaphylactic shock during intravenous fluorescein angiography at an outpatient clinic. J Chin Med Assoc 2007;70:348-9.
42. World Health Organization. Recommendations in Prevention of Blindness from Diabetes Mellitus. Report of a WHO consultation in Geneva. Geneva Switzerland; 2006. p. 3-5.
43. Bloomgarden ZT. Screening for and managing diabetic retinopathy: Current approaches. Am J Health Syst Pharm 2007;64 Suppl 12:S8-14. (Pubitemid 350202223)
44. Pandit RJ, Taylor R. Quality assurance in screening for sightthreatening diabetic retinopathy. Diabet Med 2002;19:285-91. (Pubitemid 34592153)
45. Huang OS, Lamoureux EL, Tay WT, Tai ES, Wang JJ, Wong TY. Glycemic and blood pressure control in an Asian Malay population with diabetes and diabetic retinopathy. Arch Ophthalmol 2010;128:1185-90.
46. Khandekar R, Al Lawati J, Barakat N. A retrieval system for patients with avoidable blindness due to diabetic retinopathy who do not present for ophthalmic assessment in Oman. Middle East Afr J Ophthalmol 2011;18:93-7.
47. American Academy of Ophthalmology. Diabetic Retinopathy PPP - September 2008. Available from: http://one.aao.org/CE/ PracticeGuidelines/PPP-Content. aspx?cid=d0c853d3-219f- 487b-a524-326ab3cecd9a. [Last Accessed on 2011 Jul 14].
48. Retinopathy in Clinical practice guidelines. Canadian Journal of Diabetes. Canadian Diabetes association, 2008. Available from: http://www.diabetes.ca/files/cpg2008/cpg-2008.pdf. [Last Accessed on 2011 Jul 14].
49. Grauslund J. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes. Acta Ophthalmol 2011;89:1-19.
50. Girach A, Vignati L. Diabetic microvascular complications-Can the presence of one predict the development of another? J Diabetes Complications 2006;20:228-37. (Pubitemid 43949349)
51. Jones S, Edwards RT. Diabetic retinopathy screening: A systematic review of the economic evidence. Diabet Med 2010;27:249-56.
52. Gomez-Ulla F, Alonso F, Aibar B, Gonzalez F. A comparative cost analysis of digital fundus imaging and direct fundus examination for assessment of diabetic retinopathy. Telemed J E Health 2008;14:912-8.
53. Klauss V, Schaller UC. International initiatives for the prevention of blindness. Ophthalmologe 2007;104:855-9.
54. Samb B, Desai N, Nishtar S, Mendis S, Bekedam H, Wright A, et al. Prevention and management of chronic disease: A litmus test for health-systems strengthening in low-income and middle-income countries. Lancet 2010;376:1785-97.
55. Amuna P, Zotor FB. Epidemiological and nutrition transition in developing countries: Impact on human health and development. Proc Nutr Soc 2008;67:82-90. (Pubitemid 351185360)
56. Bandurska-Stankiewicz E, Wiatr D. Diabetic blindness significantly reduced in the Warmia and Mazury Region of Poland: Saint Vincent Declaration targets achieved. Eur J Ophthalmol 2006;16:722-7. (Pubitemid 44870755)
57. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 2007;14:179-83. (Pubitemid 47493723)